Free Shipping on Orders Over $99

MK-2866 (33MG)

Regular Price
$69.95
Sale Price
$69.95
Regular Price
Sold Out
Unit Price
per 

Only -2 left!

 

MK-2866

Specification:

Unit Size 33 mg/vial
Unit Quantity 1 vial
Purity (HPLC) 97.8%
IUPAC Name (2S)-3-(4-cyano-2,3,5,6-tetradeuteriophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide
Molecular Formula C₁₉H₁₄F₃N₃O₃
Molecular Weight 389.3
CAS 1202044-20-9
Appearance Liquid
Source Chemical Synthesis
Storage Store in cool and dry environment, away from sunlight.
Terms The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering.

 

MK-2886 Ostarine, also known as enobosarm, GTx-024 or S-22, is a SARM with tissue-selective anabolic and androgenic pharmacologic activity. 

It was discovered in 1998 by a group of scientists and their research teams at Ohio State University, the University of Tennessee, and GTx. It was one of the first SARMs synthesized and studied on primates, and consequently is one of the most heavily researched. 

One study found that fat-mediating hormone expression like leptin and adiponectin mRNAs was decreased when MK-2886 Ostarine was given to adult rats. It was concluded that MK-2886 was likely to have a similar impact on AR receptors to testosterone and decrease the body fat percentage of the rat.

MK-2886 has also been shown to stimulate bone growth in rat subjects. One study removed the rat’s tibias and administered increasing levels of the MK-2886 (0.04, 0.4, and 4 mg/kg) over the course of 5 weeks. Upon receiving the highest dosage, the test subjects showed denser bone regrowth, faster bone healing, and higher levels of bone growth hormones including phosphorus and alkaline phosphatase. All the test subjects, including the ones receiving the lowest dosage, demonstrated an increased weight of gastrocnemius muscle. 

Another study found similar results, rat test subjected with clinically induced osteoporosis showed increased long bone density when treated with moderate to high dosages of MK-2866.

The final study we will mention is one that evaluated muscle growth in mice who were genetically developed to be without traditional androgen receptors and had their endogenous testosterone-producing cells removed. When they were given MK-2866 they experienced muscle growth in androgen-sensitive muscles, indicating a separate pathway, distinct from sat ARKO that encouraged muscle growth at the same level as DHT.

The primary concern for SARMs researchers today is product purity.  Nordsci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.

THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION

ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY

Mix each vial with: Bacteriostatic water. 1-2ml depending on desired dissolution.

Administration: 2- 5 mg/ daily for a minimum 12 weeks

MK-2866 (33MG)

Regular Price
$69.95
Sale Price
$69.95
Regular Price
Sold Out
Unit Price
per 
>